Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568554 · ClinicalTrials.gov registry record
Clinical Diagnosis of Acute Porphyria
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 148
- Enrollment target
NCT01568554 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 148 participants.
The verdict
NCT01568554 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a focused questionnaire and laboratory tests can better define risk factors associated with possible genetic porphyria. The investigators hypothesize that the genetic carrier state of acute porphyria is distinctive enough that the Genetic Carrier Profile the investigators devise through this study will be useful in identifying carriers of genetic porphyria among the large population with undiagnosed abdominal pain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2011-12 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568554
The ClinicalTrials.gov registry entry for NCT01568554 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01568554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568554 about?
NCT01568554 is a clinical study titled "Clinical Diagnosis of Acute Porphyria". The purpose of this study is to test whether a focused questionnaire and laboratory tests can better define risk factors associated with possible genetic porphyria. The investigators hypothesize that the genetic carrier state of acute porphyria is distinctive enough that the Genetic Carrier Profile ...
What is the current status of trial NCT01568554?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2011-12. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01568554?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.